跳至主要内容
临床试验/NCT04201899
NCT04201899已完成不适用

Hypophosphatemia in the ICU - A One-day Point Prevalence Survey

Centre Hospitalier Universitaire Vaudois4 个研究点 分布在 3 个国家目标入组 890 人开始时间: 2020年3月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
890
试验地点
4
主要终点
Prevalence of hypophosphatemia

研究概览

简要总结

The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value < 0.8 mmol/l) in international critical care settings

详细描述

The survey will be conducted on one single day in each centre (D-day), within a week defined by the project coordinator (International PI). On D-Day, the local investigators will be asked

  1. to complete questions aiming at describing their ICU (number of beds, number of patients present on D-Day, type medical/surgical/other, local phosphate reference value, presence of an hypophosphatemia treatment protocol in the ICU and route of phosphate delivery in case of hypophosphatemia)
  2. to indicate how many patients had a blood phosphate <0.08 mmol/l, for each patient with hypophosphatemia, to record the exact lowest value on D-Day, and to record age, number of days in ICU on D-Day, presence (or not) of artificial nutrition and continuous renal replacement therapy, if any phosphate administration is ongoing Data will be recorded in and electronic Case Report Form (e-CRF) in REDCap, and analysed with descriptive statistics No outcome data will be recorded (pure point-prevalence) There is no intervention

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • blood phosphate value < 0.8 mmol -

排除标准

  • Blood phosphate value >0.8 mmol/l

结局指标

主要结局

Prevalence of hypophosphatemia

时间窗: 1 day

Blood value \< 0.8 mmol/l

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mette M Berger

Principal Investigator

Centre Hospitalier Universitaire Vaudois

研究点 (4)

Loading locations...

相似试验